Quadri/Bavaria Innovation and Translational Research Award Grant

Quadri/Bavaria Innovation and Translational Research Award Grant

Status: ACTIVE
Funder: The Thoracic Surgery Foundation
Amount: Up to US $80,000
Last Updated: March 20, 2026

Summary

The Quadri/Bavaria Innovation and Translational Research Award, presented by The Thoracic Surgery Foundation, supports innovative cardiac surgery research aimed at enhancing patient outcomes. With a funding amount of $40,000 per year for up to two years, this award is open to cardiac surgeons, trainees, and researchers dedicated to advancing heart failure solutions through novel devices and translational research. By fostering collaboration and innovation, the award seeks to improve care for those suffering from cardiac diseases.

Overview

The Thoracic Surgery Foundation The Thoracic Surgery Foundation is the premier philanthropic organization in cardiothoracic surgery, with nearly four decades of dedicated investment in the work of cardiothoracic surgeons and professionals. TSF is committed to improving patient care through support for research, education, innovation, and humanitarian outreach, aiming to advance heart and lung health for all. As the charitable heart of The Society of Thoracic Surgeons, TSF collaborates globally to drive progress in cardiothoracic surgery. Through the efforts of TSF and its worldwide partners, patients with heart and lung disease experience improved longevity and a high quality of life. Quadri Bavaria Innovation and Translational Research Award Purpose Named for surgeon-inventor Arshad Quadri and aortic surgery innovator Joseph Bavaria, this award is designed to support cardiac surgeons, residents, trainees, research scientists, and other inventors in their pursuit of innovations in cardiac surgery that will create better patient outcomes for all those who suffer from cardiac disease. This award is intended for basic and pre-clinical or translational research into heart failure secondary to heart disease and revolves around the use of novel devices to lessen the burden of heart failure from end-stage valvular or other conditions, including, but not limited to, heart valve device design. Associated translational research related to function, physiology, and efficacy of novel heart valve devices also falls under the scope of the award. Award Amount $40,000 per year, for up to two years ($80,000 total)

Eligibility

You can learn more about this opportunity by visiting the funder's website. Cardiac surgeon who has completed a program leading to certification by the American Board of Thoracic Surgery or its equivalent in a country outside of the United States, or who will successfully complete such training by the grant start date, and who is within seven years of their first faculty appointmentExtending applicant eligibility beyond seven years of first faculty appointment may be considered under extraordinary circumstances. Examples include career interruptions caused by military service, health challenges, or unusual family responsibilities. Exceptions must be requested in writing and approved by the President of the TSF Board of Directors prior to the application deadlineResearch Scientist or Physician Scientist At the time of application, the applicant must hold a doctoral degree and have a faculty appointment or equivalent with demonstrated institutional commitment (salary support, research space) in a recognized academic or other not-for-profit institution; Fellows and PhD post-docs are eligible to apply only if their Department Chair can assure a promotion to faculty status by the start of the award.Resident working in a cardiac surgical clinic or laboratory research program who has not yet completed cardiothoracic surgical training.General Surgery Trainee or Cardiac Surgery Trainee who intends to pursue a career in investigative cardiac surgery.